يجب مراعاة ما يلي من إرشادات ومحاذير عند استخدام هذا العلاج: Patients who experienced an incomplete antileukemic reaction gained a next induction class by which mitoxantrone or daunorubicin was administered for 2 days and cytarabine for five times utilizing the similar day-to-day dosage plan. Response costs and median survival data https://silasm429chl2.wikifiltraciones.com/user